Cargando…
The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction
Overcoming dendritic cell (DC) dysfunction is a prerequisite for successful active immunotherapy against breast cancer. CD40 ligand (CD40L), a key molecule in the interface between T-lymphocytes and DCs, seems to be instrumental in achieving that goal. Commenting on our data that CD40L protects circ...
Autores principales: | Pinzon-Charry, Alberto, Schmidt, Chris W, López, José Alejandro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413976/ https://www.ncbi.nlm.nih.gov/pubmed/16524455 http://dx.doi.org/10.1186/bcr1386 |
Ejemplares similares
-
Spontaneous apoptosis of blood dendritic cells in patients with breast cancer
por: Pinzon-Charry, Alberto, et al.
Publicado: (2006) -
Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria
por: Pinzon-Charry, Alberto, et al.
Publicado: (2013) -
Soluble CD40 ligand is not solely related to the presence and severity of sepsis
por: Chew, Michelle S, et al.
Publicado: (2011) -
Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma
por: Vogt, Annabelle, et al.
Publicado: (2021) -
Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects?
por: Tuinman, Pieter R, et al.
Publicado: (2011)